NCT00627354 Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00626548 A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer Status TERMINATED Phase PHASE3
NCT00625430 A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer Status UNKNOWN Phase PHASE1
NCT00623831 A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen Status COMPLETED Phase PHASE1
NCT00622973 USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases Status COMPLETED Phase PHASE3
NCT00621413 Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer Status WITHDRAWN Phase N/A
NCT00620295 Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00619996 Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00619515 Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer Status TERMINATED Phase NA
NCT00617669 A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT00617617 The Specific Role of Isoflavones in Reducing Prostate Cancer Risk Status COMPLETED Phase PHASE2
NCT00616291 Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer Status COMPLETED Phase PHASE1
NCT00607932 Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer Status COMPLETED Phase NA
NCT00605488 The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer Status COMPLETED Phase NA
NCT00604526 High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy Status COMPLETED Phase PHASE1
NCT00601406 Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer Status UNKNOWN Phase NA
NCT00598858 Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate Status WITHDRAWN Phase PHASE2
NCT00598312 Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer Status COMPLETED Phase PHASE3